4.7 Article

A multimodal analysis of genomic and RNA splicing features in myeloid malignancies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Hematology

The future of research in hematology: Integration of conventional studies with real-world data and artificial intelligence

Francesco Passamonti et al.

Summary: Most national health-care systems rely on large randomized clinical trials (RCTs) for approving new drugs, but the selection biases, strict criteria, and poor treatment compliance in RCTs may not reflect real-world situations. This discrepancy, along with the limited size of RCTs, often results in the gap between evidence generated in RCTs and its translation to health-care policies. Real-world evidence (RWE) derived from real-world data (RWD) is gaining attention, especially with the help of artificial intelligence (AI), in supporting research and health-care decisions in Hematology.

BLOOD REVIEWS (2022)

Article Hematology

TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes

Carmelo Gurnari et al.

Summary: Decreased DNA dioxygenase activity from the TET2 gene family is important in MDS. The downregulation of 5-hydroxymethylcytosine (5-hmC) suggests a role for DNA demethylation in MDS beyond TET2 mutations. TET3 is upregulated in MDS as a compensatory mechanism for TET2 dysfunction, and elevated TET3 levels influence the clinical phenotype of TET2 deficiency.

BLOOD ADVANCES (2022)

Article Biochemistry & Molecular Biology

A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia

Andy G. X. Zeng et al.

Summary: A study found that the composition of leukemia cell hierarchy is associated with treatment response and drug sensitivity. By analyzing the transcriptomes of over 1,000 patients, the researchers identified four classes of leukemia cell hierarchy: Primitive, Mature, GMP, and Intermediate. Variation in hierarchy composition along the Primitive versus GMP or Primitive versus Mature axes was associated with response to chemotherapy or drug sensitivity profiles of targeted therapies.

NATURE MEDICINE (2022)

Article Medicine, General & Internal

Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q

Vera Adema et al.

Summary: This study provides an in-depth analysis of myeloid neoplasia caused by haploinsufficiency resulting from deletion of the long arm of chromosome 5 (del(5q)). The research identifies the importance of del(5q) genes in the development of the disease and establishes a gene signature that distinguishes del(5q) cases from diploid cases. The study also reveals the heterogeneity of gene expression within del(5q) patients and uncovers the balance of specific genes that drive clonal expansion.

EBIOMEDICINE (2022)

Review Immunology

Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond

Simona Pagliuca et al.

Summary: The variability of human leukocyte antigen (HLA) is important for immune responses against pathogens and tumors. Genetic alterations affecting this variability can lead to pathological processes and impact the immune system's ability to respond to diseases like cancer. This review provides an overview of the consequences of perturbations in the genomic heterogeneity of HLA complexes on human diseases, with a focus on cancer.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Complex landscape of alternative splicing in myeloid neoplasms

Courtney E. Hershberger et al.

Summary: Myeloid neoplasms exhibit frequent mutations in spliceosome components, resulting in distinct abnormal splicing signatures with little overlap. RNA-Seq analysis on a large cohort identified commonly mis-spliced transcripts and revealed the impact of splicing factor mutations on protein function.Meta-splicing analysis showed reduced levels of retained introns in disease samples, exacerbated in patients with splicing factor mutations, suggesting a common pathway by which alternative splicing may regulate cell proliferation.

LEUKEMIA (2021)

Article Oncology

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

Matteo Bersanelli et al.

Summary: The study identified eight distinct subgroups of MDS based on specific genomic features, each with different prognostic outcomes. By integrating clinical and genomic variables, a novel prognostic model was developed to provide personalized survival predictions for MDS patients. This model significantly improved the accuracy of current prognostic tools and has the potential to revolutionize disease classification and prognosis in the future.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Multidisciplinary Sciences

Fast and precise single-cell data analysis using a hierarchical autoencoder

Duc Tran et al.

Summary: Accurate analysis of single-cell RNA sequencing (scRNA-seq) data is crucial for various research fields, but is often hindered by technical noise and high dropout rates. The hierarchical autoencoder, scDHA, introduced in this study, outperforms existing methods in various aspects of scRNA-seq analysis, including cell segregation and classification.

NATURE COMMUNICATIONS (2021)

Article Education, Scientific Disciplines

Have we reached a molecular era in myelodysplastic syndromes?

Maria Teresa Voso et al.

Summary: Myelodysplastic syndromes (MDS) exhibit diverse biological and clinical features, with mutated genes playing a crucial role in diagnosis and prognosis. Specific mutations, such as SF3B1, can aid in defining MDS while others may indicate a poor prognosis. The incorporation of mutation profiles into prognostic systems can lead to more precise disease stratification and guide treatment decisions.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2021)

Article Hematology

A geno-clinical decision model for the diagnosis of myelodysplastic syndromes

Nathan Radakovich et al.

Summary: By utilizing clinical and next-generation sequencing data, a machine learning model was successfully developed for the diagnosis of myeloid malignancies independent of bone marrow biopsy data in an international patient cohort, achieving high performance. The model interpretations suggest that it relies on factors similar to those used by clinicians, and associations between NGS findings and clinically important phenotypes were described. The use of machine learning algorithms to elucidate clinicogenomic relationships was also introduced.

BLOOD ADVANCES (2021)

Review Biochemistry & Molecular Biology

How artificial intelligence might disrupt diagnostics in hematology in the near future

Wencke Walter et al.

Summary: Artificial intelligence is becoming indispensable in the healthcare sector, with applications including image processing, disease classification, and information recognition. It can help improve diagnostic accuracy and treatment success rates.

ONCOGENE (2021)

Article Oncology

Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS

Oscar E. Bruck et al.

Summary: This study utilized convolutional neural networks to extract morphologic features from bone marrow biopsies of patients with MDS and MPN, showing promising results in predicting genetic abnormalities, prognosis, and other clinical variables. By linking deep BM histopathology with genetics and clinical variables, this study highlights the potential of convolutional neural networks in understanding MDS pathology and how genetics is reflected in BM morphology.

BLOOD CANCER DISCOVERY (2021)

Article Biochemistry & Molecular Biology

Functional and conformational impact of cancer-associated SF3B1 mutations depends on the position and the charge of amino acid substitution

Christine Canbezdi et al.

Summary: The hotspot mutations of SF3B1 in cancers disrupt mRNA splicing and contribute to oncogenesis. Further research reveals varying functional consequences of SF3B1 mutations in cancers, dependent on the mutation site and amino acid substitution, suggesting unequal pathogenic and prognostic potentials.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Medicine, General & Internal

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Pierre Fenaux et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemical Research Methods

Interpretable factor models of single-cell RNA-seq via variational autoencoders

Valentine Svensson et al.

BIOINFORMATICS (2020)

Article Medicine, Research & Experimental

Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation

W. Brian Dalton et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Genetics & Heredity

Digital twins to personalize medicine

Bergthor Bjornsson et al.

GENOME MEDICINE (2019)

Article Multidisciplinary Sciences

Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia

Yusuke Shiozawa et al.

NATURE COMMUNICATIONS (2018)

Article Medicine, General & Internal

Immune Escape of Relapsed AML Cells after Allogeneic Transplantation

M. J. Christopher et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, Research & Experimental

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes

Bon Ham Yip et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Biochemistry & Molecular Biology

U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3′ End Formation

Sung Mi Park et al.

MOLECULAR CELL (2016)

Article Multidisciplinary Sciences

Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage

Samar Alsafadi et al.

NATURE COMMUNICATIONS (2016)

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Oncology

PRPF8 defects cause missplicing in myeloid malignancies

A. Kurtovic-Kozaric et al.

LEUKEMIA (2015)

Article Computer Science, Interdisciplinary Applications

Model-based clustering of high-dimensional data: A review

Charles Bouveyron et al.

COMPUTATIONAL STATISTICS & DATA ANALYSIS (2014)

Article Biochemical Research Methods

Molecular signatures database (MSigDB) 3.0

Arthur Liberzon et al.

BIOINFORMATICS (2011)

Article Multidisciplinary Sciences

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

Benjamin L. Ebert et al.

NATURE (2008)

Article Medicine, General & Internal

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

Alan List et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)